Origin Materials Inc Dossier - Source-backed chat

Origin Materials Inc

ORGNNASDAQ

SectorMaterials

IndustrySpecialty Chemicals

Beta (adjusted)1.09

Intrinsic Value

Insufficient data for a value estimateNot enough reliable inputs to publish a fair value for this company yet.

Market Price $0.95Price as of 1 Jul 2026

Data confidenceNot applicable

Market Cap $5.2M

Enterprise Value $8.9M

Shares Outstanding 5.4M diluted

All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference.

Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted

Thesis Summary

Origin Materials, Inc. has officially abandoned its commercialization and growth strategy, pivoting entirely to a wind-down and liquidation process. On April 28, 2026, the Board of Directors unanimously approved a Plan of Complete Liquidation and Dissolution, subject to stockholder approval at a Special Meeting scheduled for July 1, 2026. The company has implemented a 59% workforce reduction, suspended furanics platform and Origin 1 operations, and is actively seeking to sell its PET cap technology and remaining intellectual property. Furthermore, the company has announced its intention to voluntarily delist from the Nasdaq Capital Market on July 2, 2026, and deregister with the SEC. Consequently, the investment thesis is no longer based on business growth or operational milestones, but rather on the estimated liquidation payout to stockholders, which is highly uncertain and projected to range between $0.61 and $3.54 per share.

This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.

Our research · scenarios, merits, risks, and invalidation triggersResearch as of 19 Jun 2026

Scenarios · 12-month scenario targetsAnchored at research date

Bear CaseDownside scenario

The company fails to find buyers for its intellectual property and technology assets, or the transaction values are negligible. Outstanding liabilities, legal claims, and ongoing wind-down expenses consume the majority of the remaining cash reserves ($32.6 million as of March 31, 2026). Stockholders receive a final liquidation distribution at or near the absolute bottom of the estimated range, or potentially nothing if unforeseen liabilities emerge during the wind-down period.

Base CaseCentral scenario

Stockholders approve the Plan of Complete Liquidation and Dissolution at the Special Meeting on July 1, 2026. The company successfully delists from Nasdaq on July 2, 2026, and files Form 15 to eliminate public reporting costs. Matt Plavan (Interim CEO) and the remaining wind-down team execute an orderly sale of the PET cap technology and patent portfolio. After satisfying outstanding liabilities (totaling $46.8 million as of March 31, 2026) and establishing a contingency reserve, the company distributes remaining cash to stockholders. The initial liquidation distribution falls within the lower-to-middle end of the estimated range ($0.61 to $3.54 per share) due to transaction costs and wind-down expenses.

Bull CaseUpside scenario

The primary upside for investors lies in the orderly liquidation and wind-down process. Following the approval of the Plan of Complete Liquidation and Dissolution, the board estimates an initial cash distribution of between $0.61 and $3.54 per share of common stock as remaining non-cash assets (including its PET cap technology) are sold and liabilities are settled.

Scenarios reflect our research view at the research date.

Key Investment Merits

Estimated liquidation distribution range ($0.61 to $3.54 per share) offers potential upside if asset sales are executed at favorable valuations relative to the current micro-cap market value.
Voluntary delisting and SEC deregistration will immediately eliminate significant legal, audit, and compliance costs, preserving remaining cash for distribution.
The company holds a valuable portfolio of patents covering biomass-to-chemical conversion and PET cap designs that could attract strategic buyers.

Key Investment Risks

Complete loss of public market liquidity following the voluntary delisting from Nasdaq on July 2, 2026, with no intention to facilitate OTC trading.
High uncertainty regarding the timing and final cash amount of any liquidation distributions, which are subject to the Board's discretion and the resolution of outstanding claims.
Substantial doubt about the company's ability to continue as a going concern if the Plan of Dissolution is not approved by stockholders.

Thesis Invalidation Triggers

Rejection of the Plan of Complete Liquidation and Dissolution by stockholders at the Special Meeting on July 1, 2026.
Emergence of a superior, unsolicited strategic transaction or financing alternative prior to filing the Certificate of Dissolution that leads the Board to abandon the liquidation plan.
Unforeseen material liabilities or litigation claims that completely deplete the remaining cash reserves, leaving zero proceeds for distribution to stockholders.

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Explore this dossier

ValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework.